Sirona Biochem Corp V.SBM

Pet Deal benchmark

[noclue80]

well, seems surprisingly SBM might not be first to market with an SGLT2 for feline diabetes, but interesting to see what such a license agreement could be worth..

We're also pleased to announce today that we've licensed a revolutionary first-in-class product for feline Diabetes Care. The product introduces a new mechanism of action for veterinarians with a needle-free easy to give daily oral medication to treat this chronic condition. 
Elanco Animal Health Inc. (ELAN) Q2 2022 Earnings Call Transcript | The Motley Fool


Charges recorded in the second quarter of 2022 primarily related to a $59 million charge recorded for IPR&D related to the feline diabetes care asset Elanco licensed during the quarter and costs associated with the implementation of new systems, programs, and processes due to the integration of Bayer Animal Health. 
Elanco Animal Health Inc. - Elanco Animal Health Reports Second Quarter 2022 Results

[jimmyhorizon]

is this our pet deal without us? can you enlighten us bio? or someone else?

[Turtle4]

Signed a license agreement for a first-in-class product for feline diabetes care. The daily oral medication is under FDA regulatory review and is expected to be approved in the next 12 months. looks like there will be no animal health deal for Sirona. Elanco has another product which is already under FDA review. Sirona can't compete with that, because they can't go further then

[forhandlaren]

Not neccessarily. The competitors might choose TFC-039 to take on Elanco. It's not like the Elanco-deal has been unknown until today. Management must have some insight on existing deals - after all, I think Linda Pullan is still active in supporting management even though Howard decides in the end - unfortunately.

[biorun]

Yes, I am with you on this forhandlaren. There are 4 majors listed in the September presentation update and Elanco is only one of them.  If Elanco confirmed its a new market to pursue, others will definitely jump on board and there are really no other options here for the other 3 top 10 animal health listed to pursue and compete with Elanco on. So this could get extremely interesting to

[biorun]

I think what you just said is full of holes.

[lscfa]

BexCaFe Arrangement   On June 9, 2022, we signed a license agreement with BexCaFe, LLC (BexCaFe) for the development and commercialization of products related to an oral treatment intended to reduce glucose levels in diabetic cats. BexCaFe held the rights to the compound through a license agreement with similar terms and conditions. We will incur all development and regulatory costs

[Pandora]

In that first sentence who is "we"....

[Tyromp]

Elanco

[noclue80]

seems this BexCaFe was implemented just for this deal.. is that common if you don't want to disclose the original rights owner..? also, none of the materials talk about SGLT2 specifically, just oral treatment for feline diabetes. the first-in-class, oral daily might indicate it is SGLT2, but it's ot written anywhere..

[Turtle4]

perhaps our chinese lawyer discovered his own SGLT2 inhibitor

[biofool]

Or is this the next scam to avoid having to share the proceeds with the shareholder?